“…The majority of GTN patients present to tertiary health facilities with advanced disease, often due to delayed diagnosis and prior suboptimal management ( Mburu et al, 2022 ). The cost of cancer testing and treatment is a significant barrier facing many Kenyan people, with Kenya having the lowest health expenditure (only 3.5 % of its gross domestic product) compared to its neighbors ( Makau-Barasa et al, 2018 ).…”